Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 4.23% | 75.93 | 1.0% | $2028.13m | |
| AMGN | Amgen, Inc. | 5.15% | 208.48 | 1.3% | $944.46m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 5.22% | 473.00 | 2.6% | $802.29m | |
| BIIB | Biogen, Inc. | 6.53% | 316.13 | 1.5% | $751.59m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 6.76% | 231.92 | 1.9% | $564.30m | |
| MRNA | Moderna, Inc. | 1.43% | 30.48 | 0.0% | $562.64m | |
| ILMN | Illumina, Inc. | 2.67% | 276.23 | 3.5% | $478.28m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 3.87% | 87.26 | 2.0% | $278.63m | |
| A | Agilent Technologies, Inc. | 2.84% | 72.74 | 1.6% | $236.92m | |
| EXAS | EXACT Sciences Corp. | 0.92% | 58.43 | 21.0% | $200.66m | |
| INCY | Incyte Corp. | 4.66% | 72.17 | 2.5% | $176.73m | |
| SGEN | Seattle Genetics, Inc. | 5.51% | 115.29 | 6.1% | $169.71m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 3.75% | 82.49 | 4.3% | $160.87m | |
| NVAX | Novavax, Inc. | 9.58% | 14.30 | 114.7% | $133.52m | |
| CODX | Co-Diagnostics, Inc. | -10.38% | 8.20 | 0.0% | $107.45m |
Company Profile
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.